Valuation: Crossject

Market Cap 71.32M 80.27M 66.57M 60.67M 114M 7.72B 115M 806M 312M 3.94B 301M 295M 12.66B P/E 2026 *
3.2x
P/E 2027 * 2.52x
Enterprise Value 53.42M 60.13M 49.86M 45.45M 85.71M 5.78B 86.51M 603M 234M 2.95B 226M 221M 9.48B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.37x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
1 week-2.25%
Current month-4.69%
1 month-6.06%
3 months-26.36%
6 months-35.86%
Current year-39.16%
1 week 1.26
Extreme 1.262
1.39
1 month 1.26
Extreme 1.26
1.44
3 years 0.68
Extreme 0.677028625
5.7
5 years 0.68
Extreme 0.677028625
5.7
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%-2.25%-34.04%-65.37% 80.27M
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.25%-0.86%-13.26%+5.79% 76.69B
Weighted average by Cap. +0.03%-1.30%-17.07%+11.22%

Financials

2026 *2027 *
Net sales 60.8M 68.43M 56.75M 51.72M 97.55M 6.58B 98.46M 687M 266M 3.36B 257M 251M 10.79B 65.2M 73.38M 60.85M 55.47M 105M 7.05B 106M 736M 285M 3.61B 276M 270M 11.57B
Net income 28.3M 31.85M 26.41M 24.07M 45.41M 3.06B 45.83M 320M 124M 1.57B 120M 117M 5.02B 35.6M 40.07M 33.23M 30.29M 57.12M 3.85B 57.65M 402M 156M 1.97B 150M 147M 6.32B
Net Debt -17.9M -20.15M -16.71M -15.23M -28.72M -1.94B -28.99M -202M -78.34M -990M -75.64M -74M -3.18B -47M -52.9M -43.87M -39.98M -75.41M -5.09B -76.11M -531M -206M -2.6B -199M -194M -8.34B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Date Price Change
26-10-02 €1.302 -2.98%
26-10-01 €1.342 -1.76%
26-09-30 €1.366 +2.09%
26-09-29 €1.338 +4.86%
26-09-28 €1.276 -4.20%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.310EUR
Average target price
4.400EUR
Spread / Average Target
+235.88%

Annual profits - Rate of surprise